Welcome to Pharmacogenetic Testing Miami. Our mission is to provide our patients with the highest quality of personalized genomic testing and services. We are dedicated to helping improve the health of our patients through the use of cutting-edge genomic technologies.
Our laboratory offers a wide range of genomic services, including:
– Whole genome sequencing
– Exome sequencing
– Copy number variation analysis
– Gene expression profiling
– Pharmacogenomic testing
We are committed to providing excellence in service and support, and we are always available to answer any questions you may have. Thank you for choosing Pharmacogenetic Testing Miami.
Pharmacogenetic testing is a service that can help you to better understand how your body responds to medications. This testing can be especially helpful if you have a history of adverse drug reactions or if you are taking multiple medications. Pharmacogenetic testing can help to identify which medications are most likely to be effective for you and which ones may cause unwanted side effects. Feel free to contact us anytime day or night in Miami, Florida!
Testing and its benefits – Pharmacogenetic Testing Miami
Pharmacogenetic testing, also known as PGx testing, is a type of DNA test that can help determine how a person’s body metabolizes medication. This information can then be used to tailor medications to a person’s specific needs, making them more effective and less likely to cause side effects. Pharmacogenetic testing is becoming increasingly commonplace as its benefits are more widely recognized. In addition to reducing the risk of side effects, PGx testing can also help to optimize the efficacy of medications, leading to better health outcomes. As the use of PGx testing grows, it is likely that more and more people will benefit from its life-changing potential.
CYP1A2 Test – Pharmacogenetic Testing Miami
CYP1A2 is a gene that encodes for the CYP1A2 enzyme. CYP1A2 is responsible for metabolizing a variety of substances, including caffeine. The CYP1A2 enzyme can help to break down cancer-causing substances and potentially reduce the risk of cancer.
CYP2B6 is a gene that encodes for a liver enzyme. The enzyme helps to break down certain drugs and toxins in the body. Some people have a variation in this gene that causes them to metabolize drugs and toxins differently than people without the variation. This can lead to medication toxicity or increased drug effects.
The CYP2C9 enzyme is responsible for the metabolism of many drugs, including warfarin. Some individuals have a variation in the CYP2C9 gene that causes their CYP2C9 enzyme to work differently than most people. This can result in them being unable to metabolize warfarin properly, which can lead to an increased risk of bleeding. This includes fluoxetine, losartan, phenytoin, tolbutamide, torsemide, S-warfarin, and numerous NSAIDs
CYP2C19 – Pharmacogenetic Testing Miami
CYP2C19 is a gene that encodes for the CYP2C19 enzyme. The CYP2C19 enzyme metabolizes many drugs in the body, including some proton pump inhibitors (PPIs) used to treat acid reflux. A recent study found that people with a variation of the CYP2C19 gene are more likely to experience adverse effects from PPIs, such as acute interstitial nephritis.
CYP3A4/5 – Pharmacogenetic Testing Miami
Drugs that are CYP3A4/5 substrates are likely to be metabolized by CYP3A4/5. The CYP3A4 enzyme is responsible for the metabolism of more than 50% of all clinically prescribed drugs. CYP3A4 inhibitors and inducers can alter the clearance of CYP3A4 substrates, potentially resulting in serious drug interactions.
CYP2D6 is a gene that encodes for CYP2D6, a protein that metabolizes drugs in the body. CYP2D6 has been shown to be important in the metabolism of many drugs, including opioids and antidepressants. Some people have a variant form of the CYP2D6 gene which causes them to metabolize these drugs more slowly than other people. This can lead to problems when these people are prescribed medications which are metabolized by CYP2D6.
UGT1A4 is a liver enzyme that helps the body process toxins. When it is not working properly, it can lead to serious health problems. A recent study has shown that UGT1A4 may also play a role in the development of Alzheimer’s Disease.
UGT2B15 is a gene that codes for an enzyme that helps to break down certain toxins in the body. Studies have shown that people who have a variation of this gene are more likely to develop cancer. While there is no cure for cancer, early detection and treatment can often lead to a successful outcome.
COMT – Catechol-o-methyltransferase
COMT is an enzyme that breaks down dopamine in the brain. COMT inhibitors are being studied as a treatment for ADHD, because they reduce the amount of dopamine available in the brain. This could help to improve focus and attention span.
DRD2 – Pharmacogenetic Testing Miami
DRD2 dopamine is a neurotransmitter that is associated with the reward system in the brain. It is responsible for feelings of pleasure and euphoria. DRD2 receptors are also involved in addiction, as drugs of abuse can cause surges of dopamine that lead to addictive behaviors.
ADRAZA is a medication that is used to help control blood sugar levels in people with type 2 diabetes. ADRAZA belongs to a class of medications called DPP-4 inhibitors, which work by blocking the DPP-4 enzyme from breaking down a hormone called GLP-1. By blocking the DPP-4 enzyme, ADRAZA allows GLP-1 to work longer and helps keep blood sugar levels under control.
MTHFR is a gene that helps produce an enzyme called methylenetetrahydrofolate reductase. This enzyme is important for converting folate (a water soluble B vitamin) into its active form, which is needed to make new DNA and proteins.
SLC6A2 is a gene that codes for a protein called serotonin transporter. The serotonin transporter moves serotonin from the synaptic cleft to the presynaptic neuron, terminating the signal. SLC6A2 is also responsible for reuptake of dopamine and norepinephrine. Variations in this gene are associated with different behaviors, including creativity.
Dopamine is a neurotransmitter that is associated with the pleasure center of the brain. SLC6A3 is a protein that helps to regulate dopamine levels in the brain. A dopamine reuptake transporter, SLC6A3 helps to recycle dopamine and keep it in the synaptic cleft between neurons. This allows for more efficient communication between neurons and can help to improve cognitive function.
SLC6A4 is a protein that regulates serotonin levels in the brain. Serotonin is a neurotransmitter that affects mood, learning, and sleep. SLC6A4 is also known as the serotonin transporter. The serotonin transporter plays a role in depression and anxiety disorders.
Serotonin receptors are found in the brain and spinal cord. There are several different types of serotonin receptors, but HTR2A is one of the most important ones. HTR2A is responsible for controlling mood, anxiety, aggression, and sexual behavior. It also plays a role in learning and memory.
Serotonin-2C receptor, also known as HTR2c, is a protein that in humans is encoded by the HTR2C gene. The htr2c gene codes for a G-protein coupled receptor that is expressed in the brain. This receptor binds serotonin, and its activation results in inhibition of adenylyl cyclase and decreased intracellular cAMP levels.
If you have HLA-A*3101, you are at an increased risk for developing an adverse reaction to abacavir, a medication used to treat HIV. Abacavir is found in the medications Ziagen, Trizivir, and Epzicom. If you are prescribed one of these medications, it is important that you let your doctor know about your HLA-A*3101 status.
HLA-B*1502 – Pharamacogenetic Testing Miami FL
HLA-B*1502 is a genetic marker that has been linked to Carbamazepine.
Carbamazepine is a medication used to treat seizures and bipolar disorder.
If you have HLA-B*1502, it is important to tell your doctor before taking Carbamazepine.
Our services – Pharmacogenetic Testing Miami FL
At pharmacogenetic testing Miami, we offer a variety of services to help you better understand your genetic makeup. Our tests can help you identify how your body processes different medications, which can help you avoid adverse drug reactions. We also offer tests to help you determine your risk for certain diseases, and can provide information about your ancestry and genealogy.
At Pharmacogenetic Testing Miami, we are committed to providing our clients with the highest quality pharmaceutical services possible. This includes our dedication to pharmacogenetics testing and toxicology. Our team of experts is dedicated to ensuring that each and every client receives the best possible care. The history of pharmacogenetics dates back to the early 1960s, when it was first used to study how different people process drugs.
Pharmacogenetic Testing Miami FL
The latest in personalized medicine is here and we’re the first to offer it. pharmacogenetic testing Miami provides data-driven methodologies for creating customized treatment plans based on your genetic makeup, empowering you with more information from which to choose treatments that will work best just as they were made specially designed by our team of experts who understand how different genes can affect each person differently.